title: Comparison between xenogeneic and allogeneic adipose mesenchymal stem cells in the treatment of acute cerebral infarct: proof of concept in rats.
abstract: BACKGROUND
  Rat adipose tissue-derived-mesenchymal stem cells (rAD-MSCs) have proven to be safe in experimental animal models of stroke. However, in order to use human AD-MSCs (hAD-MSCs) as a treatment for stroke patients, a proof of concept is needed. We analyzed whether the xenogeneic hAD-MSCs were as safe and effective as allogeneic rAD-MSCs in permanent Middle Cerebral Artery Occlusion (pMCAO) in rats.
  
  
  METHODS
  Sprague-Dawley rats were randomly divided into three groups, which were intravenously injected with xenogeneic hAD-MSCs (2 × 10(6)), allogeneic rAD-MSCs (2 × 10(6)) or saline (control) at 30 min after pMCAO. Behavior, cell implantation, lesion size and cell death were evaluated. Brain markers such as GFAP (glial fibrillary acid protein), VEGF (vascular endothelial growth factor) and SYP (synaptophysin) and tumor formation were analyzed.
  
  
  RESULTS
  Compared to controls, recovery was significantly better at 24 h and continued to be so at 14 d after IV administration of either hAD-MSCs or rAD-MSCs. No reduction in lesion size or migration/implantation of cells in the damaged brain were observed in the treatment groups. Nevertheless, cell death was significantly reduced with respect to the control group in both treatment groups. VEGF and SYP levels were significantly higher, while those of GFAP were lower in the treated groups. At three months, there was no tumor formation.
  
  
  CONCLUSIONS
  hAD-MSCs and rAD-MSCs were safe and without side effects or tumor formation. Both treatment groups showed equal efficacy in terms of functional recovery and decreased ischemic brain damage (cell death and glial scarring) and resulted in higher angiogenesis and synaptogenesis marker levels.
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. mgutierrezfernandez@salud.madrid.org.
authors: María
authors: M
authors: Gutiérrez-Fernández
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. berta.rfrutos@hotmail.com.
authors: Berta
authors: B
authors: Rodríguez-Frutos
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. jaime.ramos.jrc@gmail.com.
authors: Jaime
authors: J
authors: Ramos-Cejudo
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. oteroortega.l@gmail.com.
authors: Laura
authors: L
authors: Otero-Ortega
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. blfuentesg@hotmail.com.
authors: Blanca
authors: B
authors: Fuentes
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. maytevallejo@hotmail.com.
authors: María Teresa
authors: MT
authors: Vallejo-Cremades
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. dr.sanz@hotmail.com.
authors: Borja Enrique
authors: BE
authors: Sanz-Cuesta
authors: Department of Neurology and Stroke Centre, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ (Health Research Institute), Autónoma University of Madrid, Paseo de la Castellana 261, 28046, Madrid, Spain. exuperio.diez@salud.madrid.org.
authors: Exuperio
authors: E
authors: Díez-Tejedor
mesh_terms: D000208:Acute Disease; D000273:Adipose Tissue / Q000166:cytology*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D016923:Cell Death; D002544:Cerebral Infarction / Q000150:complications / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D020244:Infarction, Middle Cerebral Artery / Q000150:complications / Q000503:physiopathology; D008297:Male; D045164:Mesenchymal Stem Cell Transplantation; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D017207:Rats, Sprague-Dawley; D014018:Tissue Distribution; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous
chemical_list: D015415:Biomarkers
references: Stroke. 2010 Sep;41(9):2064-70
references: 20616329
references: J Transl Med. 2010;8:63
references: 20584315
references: Neuroscience. 2011 Feb 23;175:394-405
references: 21144885
references: Curr Neurovasc Res. 2011 Feb;8(1):1-13
references: 21208165
references: Cytotherapy. 2011 Jul;13(6):675-85
references: 21231804
references: Cytotherapy. 2012 Jan;14(1):34-44
references: 21942842
references: J Cell Mol Med. 2012 Oct;16(10):2280-90
references: 22452968
references: Cytotherapy. 2012 Nov;14(10):1203-14
references: 22909277
references: Cell Biol Int. 2012 Nov 1;36(11):997-1004
references: 22866675
references: PLoS One. 2012;7(12):e52121
references: 23284893
references: Stroke. 2013 Feb;44(2):497-504
references: 23287782
references: Stroke. 2013 Mar;44(3):720-6
references: 23362081
references: Discov Med. 2013 Aug;16(86):37-43
references: 23911230
references: Expert Opin Biol Ther. 2013 Nov;13(11):1479-83
references: 23915288
references: Stroke. 2014 Feb;45(2):634-9
references: 24368562
references: Biomed Res Int. 2014;2014:468748
references: 24719869
references: Stem Cell Res Ther. 2013;4(1):11
references: 23356495
references: Cell Transplant. 2015;24(5):819-28
references: 24593908
references: Exp Hematol. 2004 May;32(5):414-25
references: 15145209
references: Blood. 2004 Aug 15;104(4):1217-23
references: 15100158
references: J Cereb Blood Flow Metab. 1990 Mar;10(2):290-3
references: 1689322
references: Brain Res. 1995 Feb 27;673(1):83-92
references: 7757483
references: Stroke. 1995 Nov;26(11):2135-44
references: 7482662
references: Stroke. 1997 Oct;28(10):2060-5; discussion 2066
references: 9341719
references: Neuroscientist. 2005 Oct;11(5):400-7
references: 16151042
references: Stem Cells. 2007 Feb;25(2):371-9
references: 17038675
references: Brain Res. 2007 Dec 5;1183:43-50
references: 17920570
references: Neurosci Lett. 2008 Aug 8;440(3):246-50
references: 18572314
references: J Neurosci Res. 2010 Apr;88(5):1017-25
references: 19885863
references: Cell Transplant. 2010;19(9):1073-84
references: 20412636